This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaye, K. M.
Right arrow Articles by Kieff, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaye, K. M.
Right arrow Articles by Kieff, E.

 Previous Article  |  Next Article 

J. Virol., Feb 1995, 675-683, Vol 69, No. 2
Copyright © 1995, American Society for Microbiology

The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues

KM Kaye, KM Izumi, G Mosialos and E Kieff
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115.

Recombinant Epstein-Barr viruses (EBVs) were made with mutated latent membrane protein 1 (LMP1) genes that express only the LMP1 amino- terminal cytoplasmic and six transmembrane domains (MS187) or these domains and the first 44 amino acids of the 200-residue LMP1 carboxy- terminal domain (MS231). After infection of primary B lymphocytes with virus stocks having small numbers of recombinant virus and large numbers of P3HR-1 EBV which is transformation defective but wild type (WT) for LMP1, all lymphoblastoid cell lines (LCLs) that had MS187 or MS231 LMP1 also had WT LMP1 provided by the coinfecting P3HR-1 EBV. Lytic virus infection was induced in these coinfected LCLs, and primary B lymphocytes were infected. In over 200 second-generation LCLs, MS187 LMP1 was never present without WT LMP1. Screening of over 600 LCLs infected with virus from MS231 recombinant virus-infected LCLs identified two LCLs which were infected with an MS231 recombinant without WT LMP1. The MS231 recombinant virus could growth transform primary B lymphocytes when cells were grown on fibroblast feeders. Even after 6 months on fibroblast feeder layers, cells transformed by the MS231 recombinant virus died when transferred to medium without fibroblast feeder cells. These data indicate that the LMP1 carboxy terminus is essential for WT growth-transforming activity. The first 44 amino acids of the carboxy-terminal cytoplasmic domain probably include an essential effector of cell growth transformation, while a deletion of the rest of LMP1 can be complemented by growth on fibroblast feeder layers. LMP1 residues 232 to 386 therefore provide a growth factor-like effect for the transformation of B lymphocytes. This effect may be indicative of the broader role of LMP1 in cell growth transformation.


This article has been cited by other articles:

  • Song, Y.-J., Izumi, K. M., Shinners, N. P., Gewurz, B. E., Kieff, E. (2008). IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3. Proc. Natl. Acad. Sci. USA 105: 18448-18453 [Abstract] [Full Text]  
  • Gatto, G., Rossi, A., Rossi, D., Kroening, S., Bonatti, S., Mallardo, M. (2008). Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-{kappa}B pathway. Nucleic Acids Res 36: 6608-6619 [Abstract] [Full Text]  
  • Cameron, J. E., Yin, Q., Fewell, C., Lacey, M., McBride, J., Wang, X., Lin, Z., Schaefer, B. C., Flemington, E. K. (2008). Epstein-Barr Virus Latent Membrane Protein 1 Induces Cellular MicroRNA miR-146a, a Modulator of Lymphocyte Signaling Pathways. J. Virol. 82: 1946-1958 [Abstract] [Full Text]  
  • Jansson, A., Johansson, P., Li, S., Rymo, L. (2007). Activity of the LMP1 gene promoter in Epstein-Barr virus-transformed cell lines is modulated by sequence variations in the promoter-proximal CRE site. J. Gen. Virol. 88: 1887-1894 [Abstract] [Full Text]  
  • Horikawa, T., Yang, J., Kondo, S., Yoshizaki, T., Joab, I., Furukawa, M., Pagano, J. S. (2007). Twist and Epithelial-Mesenchymal Transition Are Induced by the EBV Oncoprotein Latent Membrane Protein 1 and Are Associated with Metastatic Nasopharyngeal Carcinoma. Cancer Res. 67: 1970-1978 [Abstract] [Full Text]  
  • Brinkmann, M. M., Schulz, T. F. (2006). Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae.. J. Gen. Virol. 87: 1047-1074 [Abstract] [Full Text]  
  • Song, Y.-J., Jen, K.-Y., Soni, V., Kieff, E., Cahir-McFarland, E. (2006). IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-{kappa}B activation. Proc. Natl. Acad. Sci. USA 103: 2689-2694 [Abstract] [Full Text]  
  • Wan, J., Zhang, W., Wu, L., Bai, T., Zhang, M., Lo, K.-w., Chui, Y.-l., Cui, Y., Tao, Q., Yamamoto, M., Akira, S., Wu, Z. (2006). BS69, a Specific Adaptor in the Latent Membrane Protein 1-Mediated c-Jun N-Terminal Kinase Pathway. Mol. Cell. Biol. 26: 448-456 [Abstract] [Full Text]  
  • Cerimele, F., Battle, T., Lynch, R., Frank, D. A., Murad, E., Cohen, C., Macaron, N., Sixbey, J., Smith, K., Watnick, R. S., Eliopoulos, A., Shehata, B., Arbiser, J. L. (2005). Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. Proc. Natl. Acad. Sci. USA 102: 175-179 [Abstract] [Full Text]  
  • Everly, D. N. Jr., Mainou, B. A., Raab-Traub, N. (2004). Induction of Id1 and Id3 by Latent Membrane Protein 1 of Epstein-Barr Virus and Regulation of p27/Kip and Cyclin-Dependent Kinase 2 in Rodent Fibroblast Transformation. J. Virol. 78: 13470-13478 [Abstract] [Full Text]  
  • Cahir-McFarland, E. D., Carter, K., Rosenwald, A., Giltnane, J. M., Henrickson, S. E., Staudt, L. M., Kieff, E. (2004). Role of NF-{kappa}B in Cell Survival and Transcription of Latent Membrane Protein 1-Expressing or Epstein-Barr Virus Latency III-Infected Cells. J. Virol. 78: 4108-4119 [Abstract] [Full Text]  
  • D'Souza, B. N., Edelstein, L. C., Pegman, P. M., Smith, S. M., Loughran, S. T., Clarke, A., Mehl, A., Rowe, M., Gelinas, C., Walls, D. (2004). Nuclear Factor {kappa}B-Dependent Activation of the Antiapoptotic bfl-1 Gene by the Epstein-Barr Virus Latent Membrane Protein 1 and Activated CD40 Receptor. J. Virol. 78: 1800-1816 [Abstract] [Full Text]  
  • Luftig, M., Yasui, T., Soni, V., Kang, M.-S., Jacobson, N., Cahir-McFarland, E., Seed, B., Kieff, E. (2004). Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK{alpha}-dependent noncanonical NF-{kappa}B activation. Proc. Natl. Acad. Sci. USA 101: 141-146 [Abstract] [Full Text]  
  • Yasui, T., Luftig, M., Soni, V., Kieff, E. (2004). Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling. Proc. Natl. Acad. Sci. USA 101: 278-283 [Abstract] [Full Text]  
  • Atkinson, P. G. P., Coope, H. J., Rowe, M., Ley, S. C. (2003). Latent Membrane Protein 1 of Epstein-Barr Virus Stimulates Processing of NF-{kappa}B2 p100 to p52. J. Biol. Chem. 278: 51134-51142 [Abstract] [Full Text]  
  • Saito, N., Courtois, G., Chiba, A., Yamamoto, N., Nitta, T., Hironaka, N., Rowe, M., Yamamoto, N., Yamaoka, S. (2003). Two Carboxyl-terminal Activation Regions of Epstein-Barr Virus Latent Membrane Protein 1 Activate NF-{kappa}B through Distinct Signaling Pathways in Fibroblast Cell Lines. J. Biol. Chem. 278: 46565-46575 [Abstract] [Full Text]  
  • Dirmeier, U., Neuhierl, B., Kilger, E., Reisbach, G., Sandberg, M. L., Hammerschmidt, W. (2003). Latent Membrane Protein 1 Is Critical for Efficient Growth Transformation of Human B Cells by Epstein-Barr Virus. Cancer Res. 63: 2982-2989 [Abstract] [Full Text]  
  • Prokova, V., Mosialos, G., Kardassis, D. (2002). Inhibition of Transforming Growth Factor beta Signaling and Smad-dependent Activation of Transcription by the Latent Membrane Protein 1 of Epstein-Barr Virus. J. Biol. Chem. 277: 9342-9350 [Abstract] [Full Text]  
  • Sharp, T. V., Wang, H.-W., Koumi, A., Hollyman, D., Endo, Y., Ye, H., Du, M.-Q., Boshoff, C. (2002). K15 Protein of Kaposi's Sarcoma-Associated Herpesvirus Is Latently Expressed and Binds to HAX-1, a Protein with Antiapoptotic Function. J. Virol. 76: 802-816 [Abstract] [Full Text]  
  • Tune, C. E., Pilon, M., Saiki, Y., Dosch, H.-M. (2002). Sustained Expression of the Novel EBV-Induced Zinc Finger Gene, ZNFEB, Is Critical for the Transition of B Lymphocyte Activation to Oncogenic Growth Transformation. J. Immunol. 168: 680-688 [Abstract] [Full Text]  
  • Higuchi, M., Kieff, E., Izumi, K. M. (2002). The Epstein-Barr Virus Latent Membrane Protein 1 Putative Janus Kinase 3 (JAK3) Binding Domain Does Not Mediate JAK3 Association or Activation in B-Lymphoma or Lymphoblastoid Cell Lines. J. Virol. 76: 455-459 [Abstract] [Full Text]  
  • Lee, W., Hwang, Y.-H., Lee, S.-K., Subramanian, C., Robertson, E. S. (2001). An Epstein-Barr Virus Isolated from a Lymphoblastoid Cell Line Has a 16-Kilobase-Pair Deletion Which Includes gp350 and the Epstein-Barr Virus Nuclear Antigen 3A. J. Virol. 75: 8556-8568 [Abstract] [Full Text]  
  • Curran, J. A., Laverty, F. S., Campbell, D., Macdiarmid, J., Wilson, J. B. (2001). Epstein-Barr Virus Encoded Latent Membrane Protein-1 Induces Epithelial Cell Proliferation and Sensitizes Transgenic Mice to Chemical Carcinogenesis. Cancer Res. 61: 6730-6738 [Abstract] [Full Text]  
  • Horikawa, T., Sheen, T.-S., Takeshita, H., Sato, H., Furukawa, M., Yoshizaki, T. (2001). Induction of c-Met Proto-Oncogene by Epstein-Barr Virus Latent Membrane Protein-1 and the Correlation with Cervical Lymph Node Metastasis of Nasopharyngeal Carcinoma. Am. J. Pathol. 159: 27-33 [Abstract] [Full Text]  
  • Brown, K. D., Hostager, B. S., Bishop, G. A. (2001). Differential Signaling and Tumor Necrosis Factor Receptor-Associated Factor (Traf) Degradation Mediated by Cd40 and the Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 (Lmp1). JEM 193: 943-954 [Abstract] [Full Text]  
  • Xin, B., He, Z., Yang, X., Chan, C.-P., Ng, M.-H., Cao, L. (2001). TRADD Domain of Epstein-Barr Virus Transforming Protein LMP1 Is Essential for Inducing Immortalization and Suppressing Senescence of Primary Rodent Fibroblasts. J. Virol. 75: 3010-3015 [Abstract] [Full Text]  
  • Delecluse, H-J, Hammerschmidt, W (2000). The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy. Mol. Pathol. 53: 270-279 [Abstract] [Full Text]  
  • Munz, C., Bickham, K. L., Subklewe, M., Tsang, M. L., Chahroudi, A., Kurilla, M. G., Zhang, D., O'Donnell, M., Steinman, R. M. (2000). Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1. JEM 191: 1649-1660 [Abstract] [Full Text]  
  • He, Z., Xin, B., Yang, X., Chan, C.-p., Cao, L. (2000). Nuclear Factor-{{kappa}}B Activation Is Involved in LMP1-mediated Transformation and Tumorigenesis of Rat-1 Fibroblasts. Cancer Res. 60: 1845-1848 [Abstract] [Full Text]  
  • Izumi, K. M., McFarland, E. C., Riley, E. A., Rizzo, D., Chen, Y., Kieff, E. (1999). The Residues between the Two Transformation Effector Sites of Epstein-Barr Virus Latent Membrane Protein 1 Are Not Critical for B-Lymphocyte Growth Transformation. J. Virol. 73: 9908-9916 [Abstract] [Full Text]  
  • Kaye, K. M., Izumi, K. M., Li, H., Johannsen, E., Davidson, D., Longnecker, R., Kieff, E. (1999). An Epstein-Barr Virus That Expresses Only the First 231 LMP1 Amino Acids Efficiently Initiates Primary B-Lymphocyte Growth Transformation. J. Virol. 73: 10525-10530 [Abstract] [Full Text]  
  • Izumi, K. M., McFarland, E. C., Ting, A. T., Riley, E. A., Seed, B., Kieff, E. D. (1999). The Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 Engages the Tumor Necrosis Factor Receptor-Associated Proteins TRADD and Receptor-Interacting Protein (RIP) but Does Not Induce Apoptosis or Require RIP for NF-kappa B Activation. Mol. Cell. Biol. 19: 5759-5767 [Abstract] [Full Text]  
  • Eliopoulos, A. G., Gallagher, N. J., Blake, S. M. S., Dawson, C. W., Young, L. S. (1999). Activation of the p38 Mitogen-activated Protein Kinase Pathway by Epstein-Barr Virus-encoded Latent Membrane Protein 1 Coregulates Interleukin-6 and Interleukin-8 Production. J. Biol. Chem. 274: 16085-16096 [Abstract] [Full Text]  
  • Ballestas, M. E., Chatis, P. A., Kaye, K. M. (1999). Efficient Persistence of Extrachromosomal KSHV DNA Mediated by Latency-Associated Nuclear Antigen. Science 284: 641-644 [Abstract] [Full Text]  
  • Eliopoulos, A. G., Blake, S. M. S., Floettmann, J. E., Rowe, M., Young, L. S. (1999). Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Activates the JNK Pathway through Its Extreme C Terminus via a Mechanism Involving TRADD and TRAF2. J. Virol. 73: 1023-1035 [Abstract] [Full Text]  
  • Devergne, O., McFarland, E. C., Mosialos, G., Izumi, K. M., Ware, C. F., Kieff, E. (1998). Role of the TRAF Binding Site and NF-kappa B Activation in Epstein-Barr Virus Latent Membrane Protein 1-Induced Cell Gene Expression. J. Virol. 72: 7900-7908 [Abstract] [Full Text]  
  • Sylla, B. S., Hung, S. C., Davidson, D. M., Hatzivassiliou, E., Malinin, N. L., Wallach, D., Gilmore, T. D., Kieff, E., Mosialos, G. (1998). Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappa B through a pathway that includes the NF-kappa B-inducing kinase and the Ikappa B kinases IKKalpha and IKKbeta. Proc. Natl. Acad. Sci. USA 95: 10106-10111 [Abstract] [Full Text]  
  • Cherney, B. W., Sgadari, C., Kanegane, C., Wang, F., Tosato, G. (1998). Expression of the Epstein-Barr Virus Protein LMP1 Mediates Tumor Regression In Vivo. Blood 91: 2491-2500 [Abstract] [Full Text]  
  • Hatzivassiliou, E., Miller, W. E., Raab-Traub, N., Kieff, E., Mosialos, G. (1998). A Fusion of the EBV Latent Membrane Protein-1 (LMP1) Transmembrane Domains to the CD40 Cytoplasmic Domain Is Similar to LMP1 in Constitutive Activation of Epidermal Growth Factor Receptor Expression, Nuclear Factor-{kappa}B, and Stress-Activated Protein Kinase. J. Immunol. 160: 1116-1121 [Abstract] [Full Text]  
  • Izumi, K. M., Kieff, E. D. (1997). The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappa B. Proc. Natl. Acad. Sci. USA 94: 12592-12597 [Abstract] [Full Text]  
  • Brodeur, S. R., Cheng, G., Baltimore, D., Thorley-Lawson, D. A. (1997). Localization of the Major NF-kappa B-activating Site and the Sole TRAF3 Binding Site of LMP-1 Defines Two Distinct Signaling Motifs. J. Biol. Chem. 272: 19777-19784 [Abstract] [Full Text]  
  • VanArsdale, T. L., VanArsdale, S. L., Force, W. R., Walter, B. N., Mosialos, G., Kieff, E., Reed, J. C., Ware, C. F. (1997). Lymphotoxin-beta receptor signaling complex: Role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappa B. Proc. Natl. Acad. Sci. USA 94: 2460-2465 [Abstract] [Full Text]  
  • Izumi, K. M., Kaye, K. M., Kieff, E. D. (1997). The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 94: 1447-1452 [Abstract] [Full Text]  
  • Kieff, E. (1995). Epstein-Barr Virus -- Increasing Evidence of a Link to Carcinoma. NEJM 333: 724-726 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»